BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 3091234)

  • 1. Molecular Mechanisms of Drug Resistance and Epidemiology of Multidrug-Resistant Variants of
    Mlynarczyk-Bonikowska B; Kowalewski C; Krolak-Ulinska A; Marusza W
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Need for treatment of gonorrhea to be effective against Chlamydia trachomatis.
    Bowie WR; Ast J; Sibau L; Shaw C; Jones HD; Black WA
    Can J Infect Dis; 1993 Nov; 4(6):347-51. PubMed ID: 22346471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urethral discharge in the male.
    Bowie WR
    Can Fam Physician; 1987 Aug; 33():1863-8. PubMed ID: 21263808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis.
    Bowie WR; Shaw CE; Chan DG; Black WA
    Antimicrob Agents Chemother; 1987 Mar; 31(3):470-2. PubMed ID: 2953304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Penicillinase-producing Neisseria gonorrhoeae].
    Mroczkowski TF
    Przegl Dermatol; 1977; 64(5):627-32. PubMed ID: 413164
    [No Abstract]   [Full Text] [Related]  

  • 6. Respiratory pharmacology. Antibiotics. II. Aminoglycosides, polymyxins, vancomycin, trimethoprim-sulfamethoxazole, and pentamidine.
    Kuriyama S; Panosian C
    Clin Chest Med; 1986 Sep; 7(3):413-23. PubMed ID: 3021381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro susceptibility of 400 isolates of Neisseria gonorrhoeae in Vancouver, 1982-84.
    Bowie WR; Shaw CE; Chan DG; Jones HD; Black WA
    CMAJ; 1986 Sep; 135(5):489-93. PubMed ID: 3091234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of N Gonorrhoeae to penicillin, ampicillin, tetracycline, erythromycin, cotrimoxazole and supristol-an-in-vitro study.
    Masshoor K; Bhujwala RA; Pandhi RK; Shriniwas ; Singh OP; Bhargava NC
    Indian J Pathol Microbiol; 1980 Jul; 23(3):171-5. PubMed ID: 6780456
    [No Abstract]   [Full Text] [Related]  

  • 9. Cross-Canada survey of susceptibility of Neisseria gonorrhoeae isolates to six antimicrobial agents.
    Dillon JR; Eidus L; Diena BB
    Can Med Assoc J; 1978 Aug; 119(3):223-8. PubMed ID: 150305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in 2004-2006 in Bangui, Central African Republic; Yaoundé, Cameroon; Antananarivo, Madagascar; and Ho Chi Minh Ville and Nha Trang, Vietnam.
    Cao V; Ratsima E; Van Tri D; Bercion R; Fonkoua MC; Richard V; Talarmin A
    Sex Transm Dis; 2008 Nov; 35(11):941-5. PubMed ID: 18724270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains.
    Bala M; Ray K; Gupta SM; Muralidhar S; Jain RK
    J Antimicrob Chemother; 2007 Sep; 60(3):582-6. PubMed ID: 17604320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam.
    Mbwana J; Mhalu F; Mwakagile D; Masesa J; Moshiro C; Sandstrom E
    East Afr Med J; 1999 Jun; 76(6):330-4. PubMed ID: 10750520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION.
    KELLOGG DS; PEACOCK WL; DEACON WE; BROWN L; PIRKLE DI
    J Bacteriol; 1963 Jun; 85(6):1274-9. PubMed ID: 14047217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neisseria gonorrhoeae strains isolated in Hong Kong: in vitro susceptibility to 13 antibiotics.
    Ng WS; Anton P; Arnold K
    Antimicrob Agents Chemother; 1981 Jan; 19(1):12-7. PubMed ID: 6787976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and therapy of Chlamydia trachomatis infections.
    Bowie WR
    Drugs; 1984 May; 27(5):459-68. PubMed ID: 6723550
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.